RG6441
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 19, 2026
CENOTE: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Hoffmann-La Roche | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetic Retinopathy • Retinal Disorders
1 to 1
Of
1
Go to page
1